PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
Masaaki Mori Selected Research
Plasma Exchange
02/2008
[Plasma exchange therapy for Kawasaki disease refractory to intravenous immunoglobulin]
04/2004
Plasma exchange for refractory Kawasaki disease.
01/2004
Efficacy of plasma exchange therapy for Kawasaki disease intractable to intravenous gamma-globulin.
Articles by Research Topic
Disease
4
Juvenile Rheumatoid Arthritis (Juvenile Idiopathic Arthritis)
03/2008 - 01/2004
4
Mucocutaneous Lymph Node Syndrome (Kawasaki Disease)
02/2008 - 01/2004
2
Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2005 - 04/2002
2
Dermatomyositis (Dermatopolymyositis)
09/2004 - 12/2002
1
Infection
12/2005
1
Tuberculosis
12/2005
1
Lung Diseases (Lung Disease)
11/2004
1
Systemic Scleroderma (Systemic Sclerosis)
10/2003
Drug/Important Bio-Agent (IBA)
3
Cyclophosphamide (Cytoxan)
FDA Link
Generic
10/2005 - 12/2002
2
tocilizumab
IBA
03/2008 - 06/2005
2
TNFR-Fc fusion protein (etanercept)
FDA Link
01/2005 - 11/2004
2
gamma-Globulins (gamma-Globulin)
IBA
01/2004 - 01/2004
1
Immunoglobulins (Immunoglobulin)
IBA
02/2008
1
Interferon-gamma (Interferon, gamma)
IBA
12/2005
1
Methylprednisolone
FDA Link
Generic
10/2005
1
Methotrexate (Mexate)
FDA Link
Generic
01/2005
1
Interleukin-6 (Interleukin 6)
IBA
11/2004
1
Interleukin-8 (Interleukin 8)
IBA
11/2004
1
HLA-DRB1 antigen (HLA DRB1)
IBA
09/2004
1
Cytokines
IBA
01/2004
1
Prednisolone (Predate)
FDA Link
Generic
04/2002
1
bredinin (mizoribine)
IBA
04/2002
Therapy/Procedure
3
Plasma Exchange
02/2008 - 01/2004